NewsRoom Articles - Page 1118 of 1412

MondayMar 12, 2018 5:30 pm

Green Plains, Inc. (NASDAQ: GPRE) Starts Presentation at 30th Annual ROTH Conference

Green Plains (NASDAQ: GPRE) is a diversified commodity-processing business with operations related to ethanol production, grain handling and storage, cattle feedlots, food ingredients, and commodity marketing and logistics services. The company is the second largest consolidated owner of ethanol production facilities in the world, with 17 dry mill plants, producing nearly 1.5 billion gallons of ethanol at full capacity. In addition, the company owns a 62.5% limited partner interest and a 2.0% general partner interest in Green Plains Partners. For more information, visit the company’s website at www.gpreinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

MondayMar 12, 2018 5:30 pm

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Starts Presentation at 30th Annual ROTH Conference

Galmed Pharmaceuticals (NASDAQ: GLMD) Is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of liver diseases. The company’s current developmental focus comprises Aramchol™, a first in class, novel, once-daily, oral therapy for the treatment of non-alcoholic steatohepatitis (“NASH”) for variable populations, as well as other liver associated disorders. Galmed is currently conducting the ARREST Study, a multicenter, randomized, double-blind, placebo-controlled phase 2b clinical study intended to evaluate the efficacy and safety of Aramchol™ in subjects with NASH, who are overweight or obese, and who are pre-diabetic or type-II-diabetic. For more information, visit the company’s website…

MondayMar 12, 2018 5:30 pm

Cryoport, Inc. (NASDAQ: CYRX) Starts Presentation at 30th Annual ROTH Conference

Cryoport (NASDAQ: CYRX) is a global provider of cold chain logistics solutions for temperature-sensitive life sciences commodities. The company serves the biopharmaceutical market with logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR-T cells. The company’s solutions are used by points-of-care, CRO’s, central laboratories, pharmaceutical companies, manufacturers, and university researchers. The company also serves the reproductive medicine market, primarily in IVF and surrogacy; and the animal health market, primarily in the areas of vaccines and reproduction. Cryoport’s proprietary Cryoport Express® Shippers, Cryoportal™ Logistics Management Platform, SmartPak II™ Condition Monitoring System and geo-sensing technology, paired…

MondayMar 12, 2018 5:30 pm

Spartan Motors, Inc. (NASDAQ: SPAR) Starts Presentation at 30th Annual ROTH Conference

Spartan Motors (NASDAQ: SPAR) designs, engineers, manufactures and markets a vast array of specialty vehicles, specialty chassis, vehicle bodies and parts for the fleet and delivery, recreational vehicle (RV), emergency response, defense forces and contract assembly (light/medium-duty truck) markets. The company’s various brand names (including Spartan Motors, Spartan Specialty Vehicles, Spartan Emergency Response, Spartan Parts and Accessories; Smeal® and its family of brands, including Ladder Tower™ and UST®; and Utilimaster®, a Spartan Motors Company) are renowned for quality, durability, performance, customer service and first-to-market innovation. For more information, visit the company’s website at www.spartanmotors.com. About NetworkNewsWire NetworkNewsWire (NNW) is a…

MondayMar 12, 2018 5:30 pm

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) Starts Presentation at 30th Annual ROTH Conference

KalVista Pharmaceuticals (NASDAQ: KALV) is a clinical-stage pharmaceutical company that discovers, develops, and commercializes small molecule protease inhibitors to treat diseases with significant unmet need. The company’s proprietary portfolio comprises of novel, small molecule plasma kallikrein inhibitors primarily targeting hereditary angioedema (“HAE”) and diabetic macular edema (“DME”). KalVista’s most advanced program, KVD001, has successfully completed its first-in-human study in patients with DME and commenced a phase 2 clinical trial in 2017. For more information, visit the company’s website at www.kalvista.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of…

MondayMar 12, 2018 5:30 pm

Celsius Holdings, Inc. (NASDAQ: CELH) Starts Presentation at 30th Annual ROTH Conference

Celsius Holdings (NASDAQ: CELH) is a global company with a proprietary, clinically proven formula for its brand CELSIUS®. Celsius Holdings, Inc. has a corporate mission to become the global leader of a branded portfolio which is proprietary, clinically proven or innovative in its category, and offers significant health benefits. CELSIUS®’ original line comes in seven flavors and is also available in single serve powdered packets. CELSIUS®’ new natural line is available in six flavors that are naturally caffeinated and naturally sweetened. For more information, visit the company’s website at www.celsiusholdingsinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content…

MondayMar 12, 2018 5:24 pm

Groestlcoin ($GRS): A Multi-Purpose, Private Cryptocurrency with Sub-Atomic Fees

In the world of cryptocurrencies where projects are born and fade out repeatedly, Groestlcoin is a project that evidences simplicity, durability, and staying power. Launched in March of 2014, Groestlcoin (Crypto: GRS) started with the goal of being instant, private, and with very low fees. Steady Development The design team for Groestlcoin began with a goal toward adopting the latest advancements to create a basic, multi-purpose cryptocurrency that performs reliably quickly and cheaply. The android app for Groestlcoin was released in December of 2014 and in March of 2015 an Electrum wallet came available. In August of 2015, the Groestlcoin…

MondayMar 12, 2018 5:00 pm

ShotSpotter, Inc. (NASDAQ: SSTI) Starts Presentation at 30th Annual ROTH Conference

ShotSpotter (NASDAQ: SSTI) is a provider of gunshot detection solutions that aid law enforcement and security personnel in identifying, locating and deterring gun violence. The company provides the most trusted, scalable and reliable gunfire alert and analysis available in the marketplace, with solutions offered on a SaaS-based subscription model. ShotSpotter has deep domain experience and cumulative agency best practice experience that enable the company to deliver measurable outcomes to help mitigate gun violence. The company has multiple patents that have resulted from almost 20 years of innovation in the area of acoustic location technology. For more information, visit the company’s…

MondayMar 12, 2018 5:00 pm

Galectin Therapeutics, Inc. (NASDAQ: GALT) Starts Presentation at 30th Annual ROTH Conference

Galectin Therapeutics (NASDAQ: GALT) is a biotechnology company focused on the discovery and development and new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. The company is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. Drug candidates based on the company’s unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics’ lead development program is in non-alcoholic steatohepatitis (“NASH”) with cirrhosis, the most advanced form of NASH related fibrosis. Further…

MondayMar 12, 2018 5:00 pm

Q BioMed, Inc. (QBIO) Starts Presentation at 30th Annual ROTH Conference

Q BioMed (OTCQB: QBIO) is a biomedical acceleration and development company engaged in licensing and acquiring biomedical assets across the healthcare spectrum. The company’s focus is on offering these target assets the strategic resources, developmental support and expansion capital they require to ensure they are able to fulfill their potential for development. This enables these target assets to provide products to the patients that need them. For more information, visit the company’s website at www.QBioMed.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Green Plains, Inc. (NASDAQ: GPRE) Starts Presentation at 30th Annual ROTH Conference

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Starts Presentation at 30th Annual ROTH Conference

Cryoport, Inc. (NASDAQ: CYRX) Starts Presentation at 30th Annual ROTH Conference

Spartan Motors, Inc. (NASDAQ: SPAR) Starts Presentation at 30th Annual ROTH Conference

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) Starts Presentation at 30th Annual ROTH Conference

Celsius Holdings, Inc. (NASDAQ: CELH) Starts Presentation at 30th Annual ROTH Conference

Groestlcoin ($GRS): A Multi-Purpose, Private Cryptocurrency with Sub-Atomic Fees

ShotSpotter, Inc. (NASDAQ: SSTI) Starts Presentation at 30th Annual ROTH Conference

Galectin Therapeutics, Inc. (NASDAQ: GALT) Starts Presentation at 30th Annual ROTH Conference

Q BioMed, Inc. (QBIO) Starts Presentation at 30th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search